Harvard Bioscience (HBIO) Intangibles (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Intangibles of $60.4 million for Q1 2026, up 496.18% year-over-year from $10.1 million in Q1 2025, and up 690.59% quarter-over-quarter from $7.6 million in Q4 2025.
Harvard Bioscience (HBIO) Intangibles (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Intangibles for 17 consecutive years, with $60.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles rose 496.18% year-over-year to $60.4 million; the TTM figure through Mar 2026 stood at $60.4 million (up 496.18% YoY), while the FY2025 annual figure was $7.6 million, down 86.93% from the prior year.
- Intangibles grew to $60.4 million in Q1 2026 per HBIO's latest filing, from $7.6 million in the prior quarter.
- Across five years, Intangibles topped out at $64.7 million in Q1 2022 and bottomed at $196000.0 in Q3 2023.
- Historically, Intangibles has averaged $29.3 million across 5 years, with a median of $19.6 million in 2023.
- Annual changes were most pronounced in 2023 — Intangibles sank 99.69% — and 2025, when it jumped 29957.0%.
- Harvard Bioscience's Intangibles stood at $224000.0 in 2022, then soared by 26086.61% to $58.7 million in 2023, then slipped by 0.35% to $58.5 million in 2024, then plunged by 86.93% to $7.6 million in 2025, then jumped by 690.59% to $60.4 million in 2026.
- Business Quant data shows HBIO's Intangibles at $60.4 million in Q1 2026, $7.6 million in Q4 2025, and $218000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.14 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 448.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 8.27 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 452.74 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 13.54 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 6.40 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 2.41 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.49 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 4.07 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 60.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.49 Mn |
| Mar 31, 2026 | 60.39 Mn |
| Dec 31, 2025 | 7.64 Mn |
| Sep 30, 2025 | 218,000.00 |
| Jun 30, 2025 | 60.11 Mn |
| Mar 31, 2025 | 10.13 Mn |
| Dec 31, 2024 | 58.45 Mn |
| Sep 30, 2024 | 12.34 Mn |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 58.33 Mn |
| Dec 31, 2023 | 58.66 Mn |
| Sep 30, 2023 | 196,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 19.64 Mn |
| Dec 31, 2022 | 224,000.00 |
| Sep 30, 2022 | 62.62 Mn |
| Jun 30, 2022 | 24.22 Mn |
| Mar 31, 2022 | 64.67 Mn |
| Dec 31, 2021 | 64.89 Mn |
| Sep 30, 2021 | 65.29 Mn |